We are live on ! Find out more
OSRHW

OSR Health Warrant
OSRHW

Delisted

OSRHW was delisted on the 25th of August, 2026.

Back to rankings

16 hedge funds and large institutions have $7.52M invested in OSR Health Warrant in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+16
Holders Change %
–
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
+$28.9K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$25.1K
3
PC
Periscope Capital
Ontario, Canada
+$22.7K
4
ASM
ATW SPAC Management
New York
+$21.7K
5
BFM
Boothbay Fund Management
New York
+$21.7K

Top Sellers

No sellers this quarter

OSRHW Hedge Fund Activity: Q1 2023 in Review

16 of the 6,287 institutional investors tracked by Wall St. Rank reported a position in OSR Health Warrant (OSRHW) for Q1 2023, worth a combined $7.52M.

Buyers outnumbered sellers: 16 funds opened new OSRHW positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Mangrove Partners, opening a new position worth an estimated $28.9K.

  • 16 institutional investors held OSR Health Warrant (OSRHW) as of Q1 2023, up from 0 in Q4 2022.
  • Funds reported $7.52M of OSR Health Warrant stock for Q1 2023.
  • 16 funds opened new OSR Health Warrant positions in Q1 2023 and 0 closed out, a net change of +16 holders.
  • The largest OSR Health Warrant buyer in Q1 2023 was Mangrove Partners, an estimated $28.9K added.

Based on aggregated 13F filings for Q1 2023.